Literature DB >> 2550630

Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19.

C A Soloninka1, M J Anderson, C A Laskin.   

Abstract

Sera from patients in the acute and recovery stages of parvovirus B19 infection, and from individuals with no detectable antiparvovirus antibody were examined for the presence of anti-DNA and antilymphocyte antibodies. Sixty-eight percent of individuals recently recovered from parvovirus infection had elevated levels of antidouble stranded (ds) and antisingle stranded (ss) DNA antibodies. In addition, a cytotoxic IgM antilymphocyte antibody was detected in more than 88% of these same sera. Serial specimens from volunteers experimentally infected with parvovirus B19 were also tested for these autoantibodies and it was determined that the presence of antilymphocyte IgM was dependent on the stage of infection. The antilymphocyte IgM was occasionally detectable in sera containing rubella specific IgM (11%) or varicella zoster specific IgM (25%). However, in contrast to B19 infection, these antibodies were not cytotoxic. From the results of our study, we propose that parvovirus infection of hematologically normal individuals may be accompanied by a transient, subclinical autoimmune state.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550630

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Parvovirus infection mimicking systemic lupus erythematosus.

Authors:  Mohan Cooray; Joshua J Manolakos; Douglas S Wright; Shariq Haider; Ameen Patel
Journal:  CMAJ       Date:  2013-08-26       Impact factor: 8.262

2.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

3.  A case of parvovirus-B19 adult acute arthritis with some allergic disease clinical features.

Authors:  D Biasi; S Zeminian; P Caramaschi; A Carletto; T Manzo; L M Bambara
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

4.  Possible induction of systemic lupus erythematosus by human parvovirus.

Authors:  A P Cope; A Jones; M Brozovic; M S Shafi; R N Maini
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

5.  Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak.

Authors:  N S Gendi; K Gibson; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

6.  Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.

Authors:  Marion Dollat; Benjamin Chaigne; Grégoire Cormier; Nathalie Costedoat-Chalumeau; François Lifermann; Alban Deroux; Emilie Berthoux; Emmanuelle Dernis; Thomas Sené; Gilles Blaison; Olivier Lambotte; Benjamin Terrier; Jérémie Sellam; Luc De Saint-Martin; Laurent Chiche; Nicolas Dupin; Luc Mouthon
Journal:  BMC Infect Dis       Date:  2018-07-04       Impact factor: 3.090

7.  Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature.

Authors:  Paul Chabert; Hatem Kallel
Journal:  Eur J Case Rep Intern Med       Date:  2020-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.